Addition of zinc may benefit some being treated for COVID-19

Addition of zinc may benefit some being treated for COVID-19

(HealthDay)—For hospitalized patients with COVID-19, the addition of zinc sulfate to hydroxychloroquine and azithromycin may improve some outcomes, according to a study not yet peer reviewed and posted on medRxiv.org.

Philip M. Carlucci, from New York University Grossman School of Medicine in New York City, and colleagues collected data from for COVID-19 patients with admission dates from March 2 to April 5, 2020. Hospital outcomes were compared for patients who received hydroxychloroquine and azithromycin plus zinc (411 patients) versus those who received hydroxychloroquine and azithromycin alone (521 patients).

The researchers found that the addition of zinc sulfate had no impact on the length of hospitalization, duration of ventilation, or duration of intensive care unit (ICU) stay. Zinc sulfate increased the frequency of patients being discharged home and reduced the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients not admitted to the ICU in univariate analyses. Findings remained significant for increased frequency of being discharged home and reduction in mortality or transfer to hospice after adjustment for the time at which zinc sulfate was added to the protocol (odds ratios, 1.53 and 0.449, respectively).

"This study should not be used to guide ," the authors write. "Rather, our observations support the initiation of future randomized investigating zinc sulfate against COVID-19."


Explore further

Hydroxychloroquine seems not to cut ventilator use in COVID-19

More information: Abstract/Full Text (subscription or payment may be required)

Copyright © 2020 HealthDay. All rights reserved.

Citation: Addition of zinc may benefit some being treated for COVID-19 (2020, May 13) retrieved 15 August 2020 from https://medicalxpress.com/news/2020-05-addition-zinc-benefit-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments